SCHEMBL5164710

SCHEMBL5164710

CCCC(Oc1cccc(C(=N)NOC(=O)OC)c1)C(=O)Nc1ccc(N2CCCCC2=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
F10 P00742 13/20 0.50
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
ALDH1A1 P00352 2/20 0.42
PKM P14618 2/20 0.42
TP53 P04637 1/20 0.42
GLA P06280 1/20 0.42
KDM1A O60341 1/20 0.41
MAOB P27338 1/20 0.41
MAPT P10636 2/20 0.41
F2 P00734 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
QSOX1 O00391 1/20 0.40
LMNA P02545 1/20 0.40
PRSS1 P07477 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5164653 0.94 F10 (0.48) F10SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL5165418 0.92 F10 (0.51) F10SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL5165871 0.91 F10 (0.50) F10SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL5164723 0.91 F10 (0.50) F10SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL5164522 0.91 F10 (0.50) F10SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL5166247 0.90 F10 (0.61) F10SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL5166567 0.90 F10 (0.61) F10SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL5166188 0.89 F10 (0.61) F10SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL5163878 0.89 F10 (0.53) F10SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL5164660 0.88 F10 (0.47) F10SMN1; SMN2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1351938-B1 PHENYL DERIVATIVES MERCK PATENT GMBH (DE) 2007-04-11 EP claimed
US-20040087582-A1 Phenyl derivatives MERCK PATENT GESELLSCHAFT (DE) 2004-05-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087582-A1 Phenyl derivatives F2, F11, SERPINC1 F10 6/4885SMN1; SMN2 3430/4885NPC1 1069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.